Literature DB >> 25207359

Vitamin D status and cancer incidence and mortality.

Irene Shui, Edward Giovannucci.   

Abstract

The role of vitamin D in cancer incidence and mortality has been investigated using several approaches, including using sun exposure as a proxy for vitamin D status, assessing vitamin D intake from food and supplements, using a predicted score to estimate vitamin D status, and directly measuring circulating 25(OH)D. A variety of complementary study designs have been implemented with various strengths and limitations. Although definitive randomized control trial data are lacking, there is strong evidence for a protective relationship of vitamin D and colorectal cancer incidence. Evidence for other cancers is not as consistent. More recently, large pooling projects have begun to investigate rarer cancers, studies have investigated common variation and expression of vitamin D-related genes and their relationships to cancer, and evidence has emerged on the role of vitamin D in cancer survival. Further study is needed to answer important questions that remain about the most affected cancer sites, the timing of vitamin D exposure in relation cancer etiology duringthe life span (e.g., adolescence or adulthood), the dose-response/optimal levels required for the most benefit, and which stages of carcinogenesis (e.g., incidence or progression) are most relevant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25207359     DOI: 10.1007/978-1-4939-0437-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

Review 1.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405

2.  Physical activity, sedentary behavior, and vitamin D metabolites.

Authors:  Elizabeth A Hibler; Christine L Sardo Molmenti; Qi Dai; Lindsay N Kohler; Shaneda Warren Anderson; Peter W Jurutka; Elizabeth T Jacobs
Journal:  Bone       Date:  2015-11-24       Impact factor: 4.398

3.  Intratumoral Sterol-27-Hydroxylase (CYP27A1) Expression in Relation to Cholesterol Synthesis and Vitamin D Signaling and Its Association with Lethal Prostate Cancer.

Authors:  Nabeela A Khan; Konrad H Stopsack; Emma H Allott; Travis Gerke; Edward L Giovannucci; Lorelei A Mucci; Philip W Kantoff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-03-13       Impact factor: 4.254

4.  25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese.

Authors:  V Camozzi; A C Frigo; M Zaninotto; F Sanguin; M Plebani; M Boscaro; L Schiavon; G Luisetto
Journal:  Osteoporos Int       Date:  2016-03-30       Impact factor: 4.507

5.  Examining the association of circulating 25-hydroxyvitamin D with kidney cancer risk: a meta-analysis.

Authors:  Guangzheng Lin; Ling Ning; Di Gu; Shi Li; Zhe Yu; Qicheng Long; Li-Na Hou; Wan-Long Tan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 6.  Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules.

Authors:  Bryan L Copple; Tiangang Li
Journal:  Pharmacol Res       Date:  2015-12-17       Impact factor: 7.658

7.  Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.

Authors:  Srilatha Swami; Aruna V Krishnan; Jasmaine Williams; Abhishek Aggarwal; Megan A Albertelli; Ronald L Horst; Brian J Feldman; David Feldman
Journal:  Endocr Relat Cancer       Date:  2016-01-27       Impact factor: 5.678

Review 8.  DHPLC Elution Patterns of VDR PCR Products Can Predict Prostate Cancer Susceptibility in African American Men.

Authors:  Robert L Copeland; Desta Beyene; Victor Apprey; Mohammad R Daremipouran; Tammey J Naab; Olakunle O Kassim; Yasmine M Kanaan
Journal:  Cancer Genomics Proteomics       Date:  2017 Nov-Dec       Impact factor: 4.069

9.  Pre-treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours-a single institution pilot study.

Authors:  Julie Bienertová-Vašků; Klára Drábová; Filip Zlámal; Josef Tomandl; Michal Kýr; Zbyněk Šplíchal; Jaroslav Štěrba
Journal:  Tumour Biol       Date:  2016-01-14

10.  Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial.

Authors:  Elizabeth L Barry; Janet L Peacock; Judy R Rees; Roberd M Bostick; Douglas J Robertson; Robert S Bresalier; John A Baron
Journal:  JAMA Oncol       Date:  2017-05-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.